Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Edwards Lifesciences (EW) PT Raised to $217 at RBC Capital
July 24, 2019 6:47 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $217.00 (from $186.00) while maintaining an Outperform rating.
Big TAVR Beat; TAVR Market Accelerated In 2Q19... MoreEdwards Lifesciences (EW) PT Raised to $250 at Cowen
July 24, 2019 6:42 AM EDTCowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $210.00) while maintaining a Outperform rating.
The analyst commented, "EW printed a significant 2Q TAVR beat that will reinvigorate investor sentiment ahead of a string of anticipated back-half... More
Edwards Lifesciences (EW) Tops Q2 EPS by 5c, Offers FY and Q3 Guidance
July 23, 2019 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.38, $0.05 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.20-$5.40, versus the consensus of $5.29.... More
